Document Detail


Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC.
MedLine Citation:
PMID:  10547599     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Screening for malignant cells in the blood and bone marrow was introduced as a strategy for the improved detection of tumour spread and may predict the development of distant metastases. The sensitivity of these approaches depends on several factors, including the choice of antibody for immunocytochemistry (ICC) and the number of cells examined. In this study criteria have been defined for scoring cells reactive with a pan-cytokeratin antibody as tumour, by comparing immunostained cells in clinical samples obtained from head and neck cancer patients and a control group without epithelial malignancy. When leucocyte subfractions are prepared by density gradient separation (DGS) from central venous blood obtained from patients with advanced head and neck squamous cell carcinoma (SCC) and screened by ICC, epithelial tumour cells sediment preferentially with the mononuclear cells but may also be detected in the granulocyte (GC) fraction. Some cases were found to have more tumour cells in the GC fraction. Similar results were seen in model experiments. To increase the sensitivity of the ICC approach, the efficiency of positive immunomagnetic selection (IMS) using Dynabeads coated with an antibody recognizing the Ber-EP4 epitope has been compared with negative IMS using anti-CD45 Dynabeads. Tumour cells were recovered from bone marrow aspirates for 2/17 cases using the positive enrichment technique and for 11/17 patients following negative IMS. These findings justify prospective studies incorporating negative IMS to establish the prognostic significance of these disseminated tumour cells for this group of patients.
Authors:
M Partridge; E Phillips; R Francis; S R Li
Related Documents :
10203059 - Humanisation and characterisation of pr1a3, a monoclonal antibody specific for cell-bou...
19847259 - Pten in stromal fibroblasts suppresses mammary epithelial tumours.
8314309 - Heterogeneous response to the growth factors [egf, pdgf (bb), tgf-alpha, bfgf, il-2] on...
20527019 - The classical hodgkin's lymphoma microenvironment and its role in promoting tumour grow...
10950389 - The bystander effect mediated by the new murine gammaherpesvirus 72--thymidine kinase/5...
1966269 - Cytology of ki-1 (cd-30) positive large cell lymphoma.
21300279 - Molecular regulation of lumen morphogenesis.
8169199 - The effect of ferredoxin(bed) overexpression on benzene dioxygenase activity in pseudom...
21366549 - Resveratrol rescues camp-dependent anionic transport in the cystic fibrosis pancreatic ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of pathology     Volume:  189     ISSN:  0022-3417     ISO Abbreviation:  J. Pathol.     Publication Date:  1999 Nov 
Date Detail:
Created Date:  2000-03-13     Completed Date:  2000-03-13     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0204634     Medline TA:  J Pathol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  368-77     Citation Subset:  IM    
Copyright Information:
Copyright 1999 John Wiley & Sons, Ltd.
Affiliation:
King's College School of Medicine and Dentistry, Denmark Hill, London SE5 8RX, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, Neoplasm / immunology
Bone Marrow Neoplasms / diagnosis,  secondary
Carcinoma, Squamous Cell / pathology*,  secondary*
Centrifugation, Density Gradient
Head and Neck Neoplasms / pathology*
Humans
Immunomagnetic Separation / methods*
Immunophenotyping
Neoplastic Cells, Circulating / pathology*
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Antigens, Neoplasm

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CD40 and Bcl2 expression in squamous cell carcinoma of the lung: correlation with apoptosis, surviva...
Next Document:  CD95 ligand expression in dedifferentiated breast cancer.